Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Survodutide is another dual agonist targeting GLP-1 and glucagon receptors (without GIP), currently in Phase 3 trials
Company Announcements: Ozempic approved in Japan for the treatment of type 2 diabetes
Once in use, it can stay at room temperature (below 86F) for limited time periods
The main differences come down to potency, dosing, and tolerability
US$ 25.46
US$ 27.85
US$ 29.71
US$ 26.48
US$ 23.05
US$ 26.00
US$ 26.37
US$ 26.50
